Ronald J. Dowgiallo, D.m.d. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 376 Route 28, Harwich Port, MA 02646 Phone: 508-432-3118 Fax: 508-432-7963 |
News Archive
Onconova Therapeutics, Inc. announced two advances in the clinical development of ESTYBON (rigosertib, ON 01910.Na) in presentations at the annual meeting of the American Society of Clinical Oncology (ASCO), June 3-7, 2011, in Chicago, Illinois.
Despite the economy's negative impact on Minnesota building projects, 22 regional construction firms have been recognized by Minnesota Laborers-Employers Cooperation and Education Trust (LECET) for their commitment to worker safety in 2008.
Shionogi Limited, the London-based European subsidiary of Shionogi & Co., Ltd announced today that on 26th March 2013 the European Medicines Agency accepted its Marketing Authorisation Application submission for ospemifene for the treatment of vulvar and vaginal atrophy in post-menopausal women.
Seaside Therapeutics LLC today announced the issuance of U.S. patent 7,648,993 B2 (‘993 patent), which covers methods of treating autism with group 1 antagonists of the metabotropic glutamate receptor (mGluR) pathway. An earlier related patent, U.S. patent 6,890,931 B2 (‘931 patent), was issued in 2005 and covers methods of treating Fragile X Syndrome, the most common known cause of autism, with group 1 antagonists of the mGluR pathway.
› Verified 6 days ago